Predictors of ventricular arrhythmias in patients with left ventricular assist devices
Journal of Acute Care and Resuscitation · 2024
DOI: 10.4103/jacresus.jacresus_1_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Acute Care and Resuscitation, 2024. Verfasst von Abdelrahman Abdelaal und 1 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Continuous flow left ventricular assist device (LVAD) is used as a bridge to heart transplant or destination therapy for end-stage chronic heart failure (CHF). Ventricular arrhythmia (VA) is not an uncommon incident following LVAD implantation, which can increase the risk of mortality.
Objectives
Our study aims to identify the predictors for VA in patients with end-stage CHF following LVAD implantation. Materials and Methods: To identify studies on predictors of VA following LVAD implantation, a comprehensive PubMed, Scopus, Cochrane Library, and Web of Science database search was conducted from their inception to December 31, 2023, in compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. An electronic search was subsequently updated on March 1, 2023. Random effects model using a restricted maximum likelihood estimator was used to calculate summary risk ratios with 95% confidence intervals (95% CI).
Results
A total of 13 studies involving 4058 patients were included in the final analysis. The strongest identified predictors of VA following LVAD implantation were preoperative LVAD VA and presence of atrial fibrillation (AF) (pooled OR = 3.20, 95% CI = 2.51–4.09, I 2 = 47% P < 0.0001 and OR = 2.25, 95% CI = 1.77–2.85, I 2 = 0% P < 0.0001, respectively), coupled with CHF duration (MD = 65.43, 95% CI = 46.02–84.84, I 2 = 0% P < 0.0001). Further, advanced patient age (MD = 1.56, 95% CI = 0.79–2.27, I 2 = 12% P = 0.33), preoperative nonischemic cardiomyopathy existence (pooled OR = 1.34, 95% CI = 1.04–1.73, I 2 = 32% P = 0.18), higher left ventricular end-diastolic diameter (MD = 3.76, 95% CI = 3.02–4.50, I 2 = 10% P = 0.36), increased creatinine and bilirubin levels (MD = 0.12, 95% CI = 0.06–0.18, I 2 = 43% P = 0.14, and MD = 0.60, 95% CI = −0.01–1.20, I 2 = 47% P = 0.11, respectively), were additionally determined as possible predictors of VA following LVAD implantation.
Conclusion
Key identified predictors of VA following LVAD implantation were preoperative presence of VA and AF presence, and end-stage CHF duration.
Zitieren
APA
Abdelaal, A., & Saltah, M. (2024). Predictors of ventricular arrhythmias in patients with left ventricular assist devices. Journal of Acute Care and Resuscitation. https://doi.org/10.4103/jacresus.jacresus_1_23
Vancouver
Abdelaal A, Saltah M. Predictors of ventricular arrhythmias in patients with left ventricular assist devices. Journal of Acute Care and Resuscitation. 2024. doi:10.4103/jacresus.jacresus_1_23
BibTeX
@article{Abdelaal2024,
author = {Abdelaal, Abdelrahman and Saltah, Mohamed},
title = {Predictors of ventricular arrhythmias in patients with left ventricular assist devices},
journal = {Journal of Acute Care and Resuscitation},
year = {2024},
doi = {10.4103/jacresus.jacresus_1_23}
}
EUVIMED